相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression
Fu-Ju Chou et al.
EBIOMEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework
Aziz Khan et al.
NUCLEIC ACIDS RESEARCH (2018)
Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells
Gwang Hun Park et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth
Max A. Cheng et al.
CANCER LETTERS (2018)
ASC-J9® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3
WanYing Lin et al.
CANCER LETTERS (2018)
Theranostic Pt(IV) Conjugate with Target Selectivity for Androgen Receptor
Xiaodong Qin et al.
INORGANIC CHEMISTRY (2018)
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer
Avital Lev et al.
MOLECULAR CANCER RESEARCH (2018)
Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells
Wei Wu et al.
MOLECULAR CARCINOGENESIS (2018)
RNA-Seq revealed ATF3-regulated inflammation induced by silica
Judy Y. W. Chan et al.
TOXICOLOGY (2018)
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals
Junjie Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Effect of propofol on androgen receptor activity in prostate cancer cells
Kenichiro Tatsumi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression
Ronghao Wang et al.
EUROPEAN UROLOGY (2017)
Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis
W-Y Chen et al.
ONCOGENE (2017)
Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer
Feng Yan et al.
ONCOTARGET (2017)
Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression
Jiaqi Chen et al.
CANCER LETTERS (2017)
ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L
Ronghao Wang et al.
CANCER LETTERS (2016)
Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells
Minhui Xu et al.
JOURNAL OF UROLOGY (2016)
ATF3 is a negative regulator of inflammation in human fetal membranes
Ratana Lim et al.
PLACENTA (2016)
Echinacoside Protects Against MPP+-Induced Neuronal Apoptosis via ROS/ATF3/CHOP Pathway Regulation
Qing Zhao et al.
NEUROSCIENCE BULLETIN (2016)
Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer
Nooshin Mirkheshti et al.
ONCOTARGET (2016)
Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer
Simeng Wen et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures
Kai Sha et al.
ONCOTARGET (2015)
Role of Activating Transcription Factor 3 (ATF3) in Endoplasmic Reticulum (ER) Stress-induced Sensitization of p53-deficient Human Colon Cancer Cells to Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis through Up-regulation of Death Receptor 5 (DR5) by Zerumbone and Celecoxib
Makoto Edagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer
Jun Qin et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Determination of androgen receptor degradation enhancer ASC-J9® in mouse sera and organs with liquid chromatography tandem mass spectrometry
Shu Fang Soh et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Antiproliferative Effect of ASC-J9 Delivered by PLGA Nanoparticles against Estrogen-Dependent Breast Cancer Cells
Paolo Verderio et al.
MOLECULAR PHARMACEUTICS (2014)
ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma
Jian-Jun Xie et al.
ONCOTARGET (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
Kuo-Pao Lai et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia
Kouji Izumi et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cells
Yongqing Liu et al.
CANCER LETTERS (2013)
ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton
Xiangliang Yuan et al.
CANCER RESEARCH (2013)
Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis
Tzu-Hua Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
Steven Kregel et al.
PLOS ONE (2013)
Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
T-H Lin et al.
CELL DEATH & DISEASE (2013)
Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9® to better battle prostate cancer progression
Kouji Izumi et al.
ONCOIMMUNOLOGY (2013)
Targeting Androgen Receptor Leads to Suppression of Prostate Cancer via Induction of Autophagy
Qi Jiang et al.
JOURNAL OF UROLOGY (2012)
ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors
Shinichi Yamashita et al.
NEOPLASIA (2012)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Curcumin-Induced Apoptosis in PC3 Prostate Carcinoma Cells Is Caspase-Independent and Involves Cellular Ceramide Accumulation and Damage to Mitochondria
Ashley L. Hilchie et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
ATF3 transcription factor and its emerging roles in immunity and cancer
Matthew R. Thompson et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis
Aijin Wang et al.
BMC CANCER (2008)
Metastasis suppressors genes in cancer
Lewis J. Stafford et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3
Xiangwei Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Uma R. Chandran et al.
BMC CANCER (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer
AE Pelzer et al.
JOURNAL OF UROLOGY (2006)
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally et al.
CANCER CELL (2005)
Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation
K Tamura et al.
EMBO JOURNAL (2005)
Osteoblasts in prostate cancer metastasis to bone
CJ Logothetis et al.
NATURE REVIEWS CANCER (2005)
分享论文
